Complement in the Homeostatic and Ischemic Brain

The complement system is a component of the immune system involved in both recognition and response to pathogens, and it is implicated in an increasing number of homeostatic and disease processes. It is well documented that reperfusion of ischemic tissue results in complement activation and an inflammatory response that causes post-reperfusion injury. This occurs following cerebral ischemia and reperfusion and triggers secondary damage that extends beyond the initial infarcted area, an outcome that has rationalized the use of complement inhibitors as candidate therapeutics after stroke. In the central nervous system, however, recent studies have revealed that complement also has essential roles in synaptic pruning, neurogenesis, and neuronal migration. In the context of recovery after stroke, these apparent divergent functions of complement may account for findings that the protective effect of complement inhibition in the acute phase after stroke is not always maintained in the subacute and chronic phases. The development of effective stroke therapies based on modulation of the complement system will require a detailed understanding of complement-dependent processes in both early neurodegenerative events and delayed neuro-reparatory processes. Here, we review the role of complement in normal brain physiology, the events initiating complement activation after cerebral ischemia-reperfusion injury, and the contribution of complement to both injury and recovery. We also discuss how the design of future experiments may better characterize the dual role of complement in recovery after ischemic stroke.

• Publication year

  2015

• Venue

  Frontiers in Immunology

• Publication date

  2015-08-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fimmu.2015.00417PMID 26322048PMCID 4533015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cross-sectional and longitudinal association between hemoglobin concentration and hypertension

  2016cited by this paper
• Is plasma C3 and C4 levels useful in young cerebral ischemic stroke patients? Associations with prognosis at 3 months

  2015cited by this paper
• Neuroprotective effects of argatroban and C5a receptor antagonist (PMX53) following intracerebral haemorrhage

  2014influential reference
• Mannose-Binding Lectin Promotes Local Microvascular Thrombosis After Transient Brain Ischemia in Mice

  2014cited by this paper
• Prognostic Value of Mannose-Binding Lectin: 90-Day Outcome in Patients with Acute Ischemic Stroke

  2014cited by this paper
• Plasma levels of mannan‐binding lectin (MBL)‐associated serine proteases (MASPs) and MBL‐associated protein in cardio‐ and cerebrovascular diseases

  2013cited by this paper
• Cardioembolic and Small Vessel Disease Stroke Show Differences in Associations between Systemic C3 Levels and Outcome

  2013cited by this paper
• [Expressions of complement C1q and C3c in rat brain tissues with cerebral ischemia/reperfusion injury].

  2013cited by this paper
• Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice

  2013cited by this paper
• Pathogenic Natural Antibodies Propagate Cerebral Injury Following Ischemic Stroke in Mice

  2012influential reference
• Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.

  2012cited by this paper
• Complement Inhibition Promotes Endogenous Neurogenesis and Sustained Anti-Inflammatory Neuroprotection following Reperfused Stroke

  2012cited by this paper
• Targeting Mannose-Binding Lectin Confers Long-Lasting Protection With a Surprisingly Wide Therapeutic Window in Cerebral Ischemia

  2012cited by this paper
• Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis

  2012cited by this paper
• Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis

  2012cited by this paper
• The complement system: an unexpected role in synaptic pruning during development and disease.

  2012cited by this paper
• The Alternative Complement Pathway Propagates Inflammation and Injury in Murine Ischemic Stroke

  2012influential reference
• C5a Receptor (CD88) Inhibition Improves Hypothermia-Induced Neuroprotection in an In Vitro Ischemic Model

  2012cited by this paper
• Evolution of Reperfusion Therapies for Acute Brain and Acute Myocardial Ischemia: A Systematic, Comparative Analysis

  2012cited by this paper
• The immunology of stroke: from mechanisms to translation

  2011cited by this paper
• The Neuroprotective Effect of Genetic Mannose-Binding Lectin Deficiency Is Not Sustained in the Subacute Phase of Stroke

  2011cited by this paper
• Complement Protein C1q-Mediated Neuroprotection Is Correlated with Regulation of Neuronal Gene and MicroRNA Expression

  2011cited by this paper
• Genetic variation in complement component C3 shows association with ischaemic stroke

  2011cited by this paper
• Mannose-Binding Lectin Deficiency Is Associated With Smaller Infarction Size and Favorable Outcome in Ischemic Stroke Patients

  2011cited by this paper
• Complement Receptor 2 Is Expressed in Neural Progenitor Cells and Regulates Adult Hippocampal Neurogenesis

  2011cited by this paper
• Plasma C3 and C3a Levels in Cryptogenic and Large-Vessel Disease Stroke: Associations with Outcome

  2011cited by this paper
• The protective effect of SCR15-18 on cerebral ischemia-reperfusion injury

  2011cited by this paper
• The contribution of mannose binding lectin to reperfusion injury after ischemic stroke.

  2011cited by this paper
• Genetically-Defined Deficiency of Mannose-Binding Lectin Is Associated with Protection after Experimental Stroke in Mice and Outcome in Human Stroke

  2010influential reference
• Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice

  2010cited by this paper
• Enhanced synaptic connectivity and epilepsy in C1q knockout mice

  2010cited by this paper
• Complement Component C1q Mediates Mitochondria-Driven Oxidative Stress in Neonatal Hypoxic–Ischemic Brain Injury

  2010cited by this paper
• Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model.

  2010cited by this paper
• Complement: a key system for immune surveillance and homeostasis

  2010cited by this paper
• The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres

  2009cited by this paper
• Complement regulators and inhibitory proteins

  2009cited by this paper
• Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin.

  2009cited by this paper
• Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

  2009cited by this paper
• C3a Receptor Antagonist Attenuates Brain Injury after Intracerebral Hemorrhage

  2009influential reference
• Plasticity during stroke recovery: from synapse to behaviour

  2009cited by this paper
• Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage.

  2009influential reference
• Complement‐Derived Anaphylatoxin C3a Regulates In Vitro Differentiation and Migration of Neural Progenitor Cells

  2009cited by this paper
• The complement‐derived anaphylatoxin C5a increases microglial GLT‐1 expression and glutamate uptake in a TNF‐α‐independent manner

  2009cited by this paper
• Recombinant C1 inhibitor in brain ischemic injury

  2009cited by this paper
• Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes.

  2009cited by this paper
• Pathogenic Natural Antibodies Recognizing Annexin IV Are Required to Develop Intestinal Ischemia-Reperfusion Injury1

  2009cited by this paper
• In Situ Deposition of Complement in Human Acute Brain Ischaemia

  2009cited by this paper
• Changes in plasma levels of complement in patients with acute ischemic stroke.

  2008cited by this paper
• Interaction between the coagulation and complement system.

  2008cited by this paper
• Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum.

  2008cited by this paper
• The complement cascade: Yin–Yang in neuroinflammation – neuro‐protection and ‐degeneration

  2008cited by this paper
• PROTECTIVE EFFECT OF C5A RECEPTOR INHIBITION AFTER MURINE REPERFUSED STROKE

  2008cited by this paper
• Platelet C4d Is Associated With Acute Ischemic Stroke and Stroke Severity

  2008cited by this paper
• The complement system in the peripheral nerve: friend or foe?

  2008cited by this paper
• C3a Receptor Modulation of Granulocyte Infiltration after Murine Focal Cerebral Ischemia is Reperfusion Dependent

  2008cited by this paper
• Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo

  2008cited by this paper
• The classical complement cascade mediates CNS synapse elimination.

  2007cited by this paper
• Complement C1q and C3 Are Critical for the Innate Immune Response to Streptococcus pneumoniae in the Central Nervous System1

  2007cited by this paper
• Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death

  2007cited by this paper
• Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study

  2007cited by this paper
• Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography.

  2007cited by this paper
• Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins

  2007cited by this paper
• Expression of complement regulators and receptors on human NT2-N neurons--effect of hypoxia and reoxygenation.

  2007influential reference
• Pre‐clinical evaluation of an sLex‐glycosylated complement inhibitory protein in a non‐human primate model of reperfused stroke

  2007cited by this paper
• Complement component C1q inhibits β‐amyloid‐ and serum amyloid P‐induced neurotoxicity via caspase‐ and calpain‐independent mechanisms

  2007cited by this paper
• Activation of the Lectin Pathway by Natural IgM in a Model of Ischemia/Reperfusion Injury1

  2006cited by this paper
• Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study.

  2006cited by this paper
• Mechanisms of neural plasticity following brain injury.

  2006cited by this paper
• Mannose binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo

  2006cited by this paper
• Temporal pattern of C1q deposition after transient focal cerebral ischemia

  2006cited by this paper
• Role of complement component C5 in cerebral ischemia/reperfusion injury.

  2006cited by this paper
• Complement C3 and C-Reactive Protein Are Elevated in South Asians Independent of a Family History of Stroke

  2006cited by this paper
• Identification of the target self-antigens in reperfusion injury

  2006influential reference
• Generation of C5a in the absence of C3: a new complement activation pathway

  2006cited by this paper
• Complement Component C3 Mediates Inflammatory Injury Following Focal Cerebral Ischemia

  2006influential reference
• Complement: a novel factor in basal and ischemia‐induced neurogenesis

  2006cited by this paper
• Alterations in plasma complement levels after human ischemic stroke.

  2006cited by this paper
• The Central Role of the Alternative Complement Pathway in Human Disease1

  2006cited by this paper
• Preclinical evaluation of the neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused stroke.

  2006cited by this paper
• Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex.

  2005cited by this paper
• C1q-Deficiency Is Neuroprotective Against Hypoxic-Ischemic Brain Injury in Neonatal Mice

  2005cited by this paper
• Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxic-ischemic central nervous system of human newborn infants.

  2005cited by this paper
• C5b-9 Terminal Complex Protects Oligodendrocytes from Apoptotic Cell Death by Inhibiting Caspase-8 Processing and Up-Regulating FLIP1

  2005cited by this paper
• Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

  2005influential reference
• [Complement componenets, C3 and factors B, in the blood of patients with acute ischemic stroke].

  2005cited by this paper
• Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis.

  2005cited by this paper
• The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats.

  2005cited by this paper
• C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation.

  2005cited by this paper
• [Complement componenets, C3 and factors B, in the blood of patients with acute ischemic stroke].

  2005cited by this paper
• C3a expressed in the central nervous system protects against LPS-induced shock.

  2005cited by this paper
• Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.

  2004cited by this paper
• Characterization of C3a and C5a Receptors in Rat Cerebellar Granule Neurons during Maturation

  2004cited by this paper
• The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation

  2004cited by this paper
• The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q.

  2004cited by this paper
• Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM.

  2004cited by this paper
• The alternative pathway of complement in disease: opportunities for therapeutic targeting.

  2004cited by this paper
• Human C-Reactive Protein Increases Cerebral Infarct Size after Middle Cerebral Artery Occlusion in Adult Rats

  2004cited by this paper
• Systemic complement activation following human acute ischaemic stroke

  2004cited by this paper
• Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury.

  2004cited by this paper
• Activation of Complement in the Central Nervous System

  2003cited by this paper

• Complement at the Nano–Neuroimmune Interface: A Hypothesis-Driven Perspective on Opioid Use Disorder

  2026cites this paper
• The Complex Role of the Complement C3a Receptor (C3aR) in Cerebral Injury and Recovery Following Ischemic Stroke

  2025cites this paper
• Altered Neuroinflammatory Transcriptomic Profile in the Hippocampal Dentate Gyrus Three Weeks After Lateral Fluid Percussion Injury in Rats

  2025cites this paper
• A percolation phase transition controls complement protein coating of surfaces.

  2025cites this paper
• The complement system and kidney cancer: pathogenesis to clinical applications

  2025cites this paper
• Transcriptome analysis reveals that the injection of mesenchymal stem cells remodels extracellular matrix and complement components of the brain through PI3K/AKT/FOXO1 signaling pathway in a neuroinflammation mouse model.

  2025cites this paper
• Immunologic Pretreatment of Donor Tissue in Vascularized Composite Allotransplantation: A Systematic Review.

  2025cites this paper
• Complement inhibition targets a rich-club within the neuroinflammatory network after stroke to improve radiographic and functional outcomes

  2025cites this paper
• Complement proteins changes in ischemic stroke patients and their relation to outcome.

  2025cites this paper
• Targeted strategy by curcumin and tideglusib biomimetic nano-systems alleviates oxidative stress and inflammation under ischemic stroke

  2025cites this paper
• Soluble Biomarkers of Cerebrovascular Pathologies.

  2024cites this paper
• The Impact of the Histone Deacetylase Inhibitor—Sodium Butyrate on Complement-Mediated Synapse Loss in a Rat Model of Neonatal Hypoxia–Ischemia

  2024influential citation
• No Short-Term Effect of Low-Dose Nicotine on Inflammation after Global Hypoxia in Newborn Piglets

  2024cites this paper
• Novel Therapeutic Mechanisms and Strategies for Intracerebral Hemorrhage: Focusing on Exosomes

  2024cites this paper
• Complement-dependent neuroinflammation in spinal cord injury: from pathology to therapeutic implications

  2024cites this paper
• VGF is required for recovery after focal stroke.

  2023cites this paper
• UCHL1 facilitates protein aggregates clearance to enhance neural stem cell activation in spinal cord injury

  2023cites this paper
• Neuroinflammation in Acute Ischemic and Hemorrhagic Stroke

  2023cites this paper
• Evaluating the comorbidities of age and cigarette smoking on stroke outcomes in the context of anti-complement mitigation strategies

  2023cites this paper
• Complement: The Road Less Traveled.

  2023cites this paper
• Multiplexed mRNA analysis of brain-derived extracellular vesicles upon experimental stroke in mice reveals increased mRNA content with potential relevance to inflammation and recovery processes

  2022cites this paper
• Contributions of animal models to mechanistic understandings of antibody‐dependent disease and roles of the amplification loop

  2022cites this paper
• Regulation of N6-methyladenosine (m6A) RNA methylation in microglia-mediated inflammation and ischemic stroke

  2022cites this paper
• Exosomes-based therapy of stroke, an emerging approach toward recovery

  2022cites this paper
• CXCL13 expressed on inflamed cerebral blood vessels recruit IL-21 producing TFH cells to damage neurons following stroke

  2022cites this paper
• Blocking C3d+/GFAP+ A1 Astrocyte Conversion with Semaglutide Attenuates Blood-Brain Barrier Disruption in Mice after Ischemic Stroke

  2022cites this paper
• Immunopathology of terminal complement activation and complement C5 blockade creating a pro‐survival and organ‐protective phenotype in trauma

  2022cites this paper
• New Candidates for Biomarkers and Drug Targets of Ischemic Stroke—A First Dynamic LC-MS Human Serum Proteomic Study

  2022cites this paper
• Therapeutic Hypothermia Inhibits the Classical Complement Pathway in a Rat Model of Neonatal Hypoxic-Ischemic Encephalopathy

  2021cites this paper
• Multiplexed mRNA analysis of brain-derived extracellular vesicles upon experimental stroke in mice reveals increased mRNA content related to inflammation and recovery processes

  2021cites this paper
• Modulation of the Complement System by Neoplastic Disease of the Central Nervous System

  2021cites this paper
• The Role of Complement in Synaptic Pruning and Neurodegeneration

  2021cites this paper
• UCHL1 inhibited by A1 astrocytes facilitates aggregates clearance to promote neural stem cells activation after spinal cord injury

  2021cites this paper
• High serum complement component C4 as a unique predictor of unfavorable outcomes in diabetic stroke

  2021cites this paper
• Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease

  2021cites this paper
• Complement Drives Synaptic Degeneration and Progressive Cognitive Decline in the Chronic Phase after Traumatic Brain Injury

  2021cites this paper
• The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets

  2021cites this paper
• Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications

  2021cites this paper
• Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics

  2021cites this paper
• Investigating the Role of VGF and Its Associated Neuropeptides in Post-Stroke Recovery and Repair

  2020cites this paper
• Complement System in Brain Architecture and Neurodevelopmental Disorders

  2020cites this paper
• An Animal Trial on the Optimal Time and Intensity of Exercise after Stroke

  2020cites this paper
• Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India

  2020cites this paper
• Does Complement-Mediated Hemostatic Disturbance Occur in Traumatic Brain Injury? A Literature Review and Observational Study Protocol

  2020cites this paper
• Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy

  2020cites this paper
• Longitudinal Stroke Recovery Associated With Dysregulation of Complement System—A Proteomics Pathway Analysis

  2020cites this paper
• Quantitative Proteomics Reveals the Beneficial Effects of Low Glucose on Neuronal Cell Survival in an in vitro Ischemic Penumbral Model

  2020cites this paper
• Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?

  2020cites this paper
• The combination of CC chemokine receptor type 5(CCR5) and Treg cells predicts prognosis in patients with ischemic stroke.

  2020cites this paper
• Thermal stress–induced oxidative damages in the liver and associated death in fish, Labeo rohita

  2020cites this paper
• The complement cascade at the Utah microelectrode-tissue interface.

  2020cites this paper
• Zika Virus Infection Modulates Expression of Regulatory Complement Factors in SH- SY5Y Cells by

  2020cites this paper
• Thermal stress–induced oxidative damages in the liver and associated death in fish, Labeo rohita

  2020influential citation
• Salidroside Restores an Anti-inflammatory Endothelial Phenotype by Selectively Inhibiting Endothelial Complement After Oxidative Stress

  2019cites this paper
• Persistent Infection with Herpes Simplex Virus 1 and Alzheimer’s Disease—A Call to Study How Variability in Both Virus and Host may Impact Disease

  2019cites this paper
• SVCT2 Promotes Neural Stem/Progenitor Cells Migration Through Activating CDC42 After Ischemic Stroke

  2019cites this paper
• Therapeutic Modulation of the Complement Cascade in Stroke

  2019cites this paper
• C3aR signaling and gliosis in response to neurodevelopmental damage in the cerebellum

  2019cites this paper
• Immunomodulatory Therapeutic Strategies in Stroke

  2019cites this paper
• Neuroimmune responses in the developing brain following traumatic brain injury.

  2019cites this paper
• Significance of Complement System in Ischemic Stroke: A Comprehensive Review

  2019cites this paper
• Beta-glucan attenuates cerebral ischemia/reperfusion-induced neuronal injury in a C57BL/J6 mouse model

  2019cites this paper
• The Inflammatory Response and Its Effect on Rehabilitation-Induced Repair Processes After Stroke

  2018cites this paper
• From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus

  2018cites this paper
• Inhibition of Complement Drives Increase in Early Growth Response Proteins and Neuroprotection Mediated by Salidroside After Cerebral Ischemia

  2018cites this paper
• Hemodynamic study about laminar shear stress extenuate cerebral ischaemia-reperfusion injury

  2018cites this paper
• Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice

  2018influential citation
• The peripheral immune response after stroke—A double edge sword for blood‐brain barrier integrity

  2018cites this paper
• The role of the complement system in traumatic brain injury: a review

  2018influential citation
• Complement C3a: Shaping the Plasticity of the Post-stroke Brain

  2018cites this paper
• Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma

  2018cites this paper
• Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury

  2018cites this paper
• The immune system and stroke: from current targets to future therapy

  2018cites this paper
• Complement Component C3 Promotes Cerebral Ischemia/Reperfusion Injury Mediated by TLR2/NFκB Activation in Diabetic Mice

  2018cites this paper
• The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor

  2018cites this paper
• Chronic Cerebral Ischemia-Induced Memory Impairment After Inhibition of BDNF by Interleukin-1 Signaling Pathway

  2017cites this paper
• Molecular Mechanisms of Inflammation in Stroke

  2017cites this paper
• Ontogeny and function of murine epidermal Langerhans cells

  2017cites this paper
• Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement

  2017cites this paper
• Translational Research in Stroke

  2017influential citation
• Schisantherin A attenuates ischemia/reperfusion-induced neuronal injury in rats via regulation of TLR4 and C5aR1 signaling pathways.

  2017cites this paper
• Increased activity of the complement system in cerebrospinal fluid of the patients with Non-HIV Cryptococcal meningitis

  2017influential citation
• The Interplay of MicroRNAs in the Inflammatory Mechanisms Following Ischemic Stroke

  2017cites this paper
• Identification of the interactome between fish plasma proteins and Edwardsiella tarda reveals tissue-specific strategies against bacterial infection.

  2016cites this paper
• Injury site‐specific targeting of complement inhibitors for treating stroke

  2016cites this paper
• Inflammogenesis of Secondary Spinal Cord Injury

  2016cites this paper
• Lectin Complement Pathway and Its Bloody Interactions in Brain Ischemia

  2016cites this paper
• Thromboembolic Model of Cerebral Ischemia and Reperfusion in Mice.

  2016cites this paper
• The dual role of complement in cancer and its implication in anti-tumor therapy.

  2016cites this paper
• Inflammation and Stroke: An Overview

  2016cites this paper
• Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement

  2015cites this paper